Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.
| Data(s) |
2010
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_409541E41FAB isbn:1528-0012[electronic], 0016-5085[linking] pmid:20682320 doi:10.1053/j.gastro.2010.07.048 isiid:000283651100028 |
| Idioma(s) |
en |
| Fonte |
Gastroenterology, vol. 139, no. 5, pp. 1526-37, 1537.e1 |
| Palavras-Chave | #Administration, Oral; Adolescent; Adult; Budesonide/administration & dosage; Dose-Response Relationship, Drug; Double-Blind Method; Endoscopy, Gastrointestinal; Eosinophilia/drug therapy; Eosinophilia/pathology; Esophagitis/drug therapy; Esophagitis/pathology; Female; Follow-Up Studies; Glucocorticoids/administration & dosage; Humans; Intestinal Mucosa/drug effects; Intestinal Mucosa/pathology; Male; Retrospective Studies; Treatment Outcome; Young Adult |
| Tipo |
info:eu-repo/semantics/article article |
